(607) 227-8695info@prendismo.com

David Sinclair Shares Thoughts on Time Requirements of Being a Scientist and Entrepreneur

Copyright © Cornell University Play All Videos in Case

Total Case Duration :

  • Date Added : 6/2/2005
  • Clip Duration : 1 min. 12 sec.

Playlists

Please Login to create playlists

David Sinclair

  • Co-founder, Sirtris Pharmaceuticals
  • male
  • Caucasian
  • 1969 (Age: 55 years old)
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • Video 1 of 8 in this Case
  • View All Available Videos

Biography

David Sinclair, Ph.D. is a co-founder of Sirtris Pharmaceuticals and Associate Professor of Pathology at Harvard Medical School. He has made key contributions to the scientific understanding of aging. In 1997, David identified the cause of aging in yeast, a first for any species, and in 2003 reported the discovery of a conserved master regulatory gene controlling this process. David has authored more than 20 peer-reviewed scientific publications, including several seminal papers in Nature and Science, and has received numerous awards and honors for his research.

David Sinclair performed his post-doctoral work with Dr. Leonard Guarente at MIT and holds a PhD in Biochemistry and Molecular Genetics from the University of New South Wales.

Often I am asked what was unexpected about my experience. And the answer to that is you know, I could talk all day about what I have learned. But really the big things for a researcher like myself that I have learned are that it takes more time than I even dreamed of to put this together. Y...(Full transcript available to logged in subscribers.).

Register & Subscribe Login

David Sinclair videos

Video 1 of 8 David Sinclair Shares Thoughts on Time Requirements of Being a Scientist and Entrepreneur
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Sinclair
  • 1 min. 12 sec.
Video 2 of 8 David Sinclair Discusses Challenge of Being An Academic In the Business World and the Roles He Has Played Within His Company
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Sinclair
  • 2 min. 22 sec.
Video 3 of 8 David Gottlieb Discusses Importance of Reducing Risk In Transitioning Technology To A Commercial Enterprise
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 1 min. 35 sec.
Video 4 of 8 David Gottlieb States Importance of Having a Business Plan Before Seeking Financing
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 1 min. 44 sec.
Video 5 of 8 David Gottlieb Discusses Importance of Process of Planning
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 4 min. 26 sec.
Video 6 of 8 David Gottlieb States Initial Public Offering May Not Be Too Far Off As A Financing Option
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 2 min. 50 sec.
Video 7 of 8 David Gottlieb States Importance of Remembering To Build The Company While Raising Capital
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 1 min. 14 sec.
Video 8 of 8 David Sinclair Shares Thoughts on Conflict Of Interest Between Academic Role and Business Role
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Sinclair
  • 2 min. 40 sec.

RELATED VIDEOS

David Sinclair Shares Thoughts on Time Requirements of Being a Scientist and Entrepreneur
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Sinclair
  • 1 min. 12 sec.
David Sinclair Discusses Challenge of Being An Academic In the Business World and the Roles He Has Played Within His Company
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Sinclair
  • 2 min. 22 sec.
David Gottlieb Discusses Importance of Reducing Risk In Transitioning Technology To A Commercial Enterprise
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 1 min. 35 sec.
David Gottlieb States Importance of Having a Business Plan Before Seeking Financing
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 1 min. 44 sec.
David Gottlieb Discusses Importance of Process of Planning
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 4 min. 26 sec.
David Gottlieb States Initial Public Offering May Not Be Too Far Off As A Financing Option
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 2 min. 50 sec.
David Gottlieb States Importance of Remembering To Build The Company While Raising Capital
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Gottlieb
  • 1 min. 14 sec.
David Sinclair Shares Thoughts on Conflict Of Interest Between Academic Role and Business Role
  • Invention to Venture - June 2005 - Session 7 - Financing Life Sciences
  • 6/2/2005
  • David Sinclair
  • 2 min. 40 sec.